General Catalyst
Capital Type
Venture Capital
Investment Size
Undisclosed / varies by deal
Geographic Scope
US, Europe, Global
Return Model
Dilutive
Stage Focus
Seed to Growth
Modality Focus
Diagnostics, AI / data, Platforms
Overview
Large venture platform with a meaningful healthcare practice and documented participation in infectious-disease diagnostics financing.
Portfolio and Signals
Not AMR-dedicated, but its Karius exposure makes it a credible tier-3 inclusion for diagnostics and data-rich infection platforms.
Access and Engagement
Access depends heavily on networks, growth potential, and category leadership.
Notable AMR Examples / Programs
Karius
Stay Updated
Stay connected so that you don't miss the latest AMR insights and updates.
